Pharmaceutical Glass Packaging Market Size, Share & Trends Report

Pharmaceutical Glass Packaging Market Size, Share & Trends Analysis Report By Drug Type (Generic, Branded, Biologic), By Product (Vials, Ampoules, Bottles, Cartridges & Syringes), By Region, And Segment Forecasts, 2021 - 2028

  • Published Date: Feb, 2021
  • Base Year for Estimate: 2020
  • Report ID: GVR-2-68038-175-7
  • Format: Electronic (PDF)
  • Historical Data: 2017 - 2019
  • Number of Pages: 208

Report Overview

The global pharmaceutical glass packaging market size was valued at USD 15.99 billion in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 8.6% from 2021 to 2028. Extensive utilization of generic injectable drugs coupled with high demand from the pharma industry is anticipated to drive the market growth. Glass poses as a hindrance to atmospheric gases, such as carbon dioxide and oxygen, from entering the primary container, mitigating the risk of contamination of the drugs. Glass packaging lowers the drug’s susceptibility to degradation, such as hydrolysis and oxidation. Moreover, it helps in resisting the escape of volatile ingredients, thereby increasing the drug stability. All these factors are anticipated to surge the product demand in near future.

The U.S. pharmaceutical glass packaging market size, by product, 2017 - 2028 (USD Million)

Growth in the global pharma market slowed considerably in 2017 due to the slow growth of the industry in emerging markets as a result of low to moderate demand for pharm products. This was seen particularly in the case of the U.S., which is the world’s largest and the most important pharmaceuticals market. The sales of injection drugs were majorly affected within the market. However, the growing importance of generic drugs and access to better healthcare services in the economy is anticipated to provide opportunities to the market.

The growing significance of cost-sensitivity and biotech drugs in the healthcare sector has resulted in the establishment of strict regulations related to drug delivery products. Several manufacturers in the market are focused on developing packaging solutions aimed at increasing the shelf life of a product and are therefore investing in vials.

The pharma glass packaging developers have been enhancing their product capabilities to cater to the changing industry needs. Gerresheimer AG, for instance, has developed a metal-free 1 ml Gx RTF long Luer Lock syringe. This syringe uses a new technology where the pin used to shape the cone is made of a special ceramic material instead of the conventional tungsten or alternative metal.

The additional impact of the Covid-19 pandemic has left the pharma industry with a steadily growing demand for medicines and other healthcare facilities. The surge in demand for pharmaceutical drugs, as a result of the pandemic, had a positive impact on the market growth. The demand is expected to reach a new peak in the case of approval for Covid-19 vaccines developed by different institutions and companies in various countries.

Product Insights

The bottles was the largest product segment in 2020 and accounted for over 35% of the overall revenue share. The market has been segmented on the basis of product into ampoules, bottles, vials, syringes and cartridges. Glass bottles used for pharma packaging are categorized into two types, small and large bottles. The large glass bottles are used for the packaging of reagents as well as transfusion and infusion bottles. The small glass bottles are used for the packaging of syrup bottles and other oral liquids.

The small bottles segment is expected to witness considerable growth on account of numerous new opportunities including the rising consumption of oral tablets that are packaged in small bottles. Vials have high analytical performance and great sustainability, which is expected to drive the segment with the second-fastest growth rate after ampoules during the forecast years. Vials are made from Type 1 borosilicate glass, which imparts the desired chemical resistance properties to the glass vials.

Ampoules is expected to be the fastest-growing product segment from 2021 to 2028. Ampoules that are largely developed from glass are anticipated to grow with the most attractive CAGR, in terms of revenue, during the forecast period owing to their high microbiological control and high chemical resistance and the ability of glass to filter specific wavelengths. A large number of ampoules are produced in compliance with the DIN ISO EN 9187-1/2 standard in sealed designs, funnel-type, and straight-stem.

Drug Type Insights

Generic drug type led the market and accounted for more than 71% share of the global revenue in 2020. The global market for generic drugs has seen high growth in the past few years due to increasing cases of chronic diseases, a growing aging population, and a rise in the expiration of drug patents. Furthermore, the efforts from governments and healthcare service providers to reduce the healthcare expenditure & drug prices and provision of health insurance coverage are anticipated to fuel the consumption of generic drugs. This is expected to ascend the demand for pharma glass packaging.

Global pharmaceutical glass packaging market share, by drug type, 2020 (%)

The high demand for biologic drugs is attributed to their ability to treat chronic diseases, especially certain forms of autoimmune diseases and cancer. However, glass delamination and chipping that results from surface degradation is anticipated to lower the growth of primary glass packaging for biologic drugs. The generic drug segment in North America is expected to witness a higher growth than branded segment, both in terms of volume and revenue, as it is affordable, whereas the patent expirations are going to further led the branded segment to have a moderate growth rate. The primary glass packaging is expected to show a sluggish growth on account of decreased volume sales of branded drugs.

The pharma industry is expected to largely benefit from biologics as they cater to therapeutic aspects that are underserved. The biosimilar competition for biologics has remained low resulting in moderate growth of the segment, thereby slowing the growth of the segment in the market. The U.S. is home to many pharma giants and therefore is expected to be a key region for various business activities related to pharma glass packaging. The customer consolidation and increased competitive intensity in the country is expected to result in a significant increase in the volume of generic drug sales causing rapid change in market dynamics. This change coupled with patent expirations of numerous drugs is expected to constrain the branded product sales in the country.

Regional Insights

North America led the market and accounted for more than 36% of the global revenue share in 2020. The developing markets are expected to witness a surge in spending in the pharma industry over the upcoming years. The U.S. is expected to remain a key driver and most important market for the growth of the pharmaceutical sector in the region with innovative products leading the growth. This growth is expected to be also aided by the rise in generics in the region that are anticipated to witness consistently high demand, in terms of volume and sales.

Asia Pacific is expected to register the fastest CAGR over the forecast period. Increased cases of chronic ailments, increased healthcare awareness, and rising income levels are expected to aid the growth of emerging markets in Asia Pacific. The governments in the Asia Pacific region are expanding their private and public healthcare coverage as a result of the increased awareness. The efforts of governments in developing economies to promote low-cost generic drugs and reduce healthcare costs are expected to result in an increased volume of pharma products further fueling the market growth in APAC.

Moreover, the presence of numerous small- and medium-scaled production units in the region supports market growth. The region also enjoys lenient regulatory regimes, which work out to support the manufacturers, along with attracting foreign investments. Usually, companies like Corning and Schott AG partners up with small-scale production units in the region, which provides them a platform to expand their regional presence along with gaining higher market share.

Europe region accounted for more than 18% of the volume share in 2020. The research-based pharma industry is a key asset of the European economy. The pharmaceutical glass packaging market is on the rise owing to rising R&D and the introduction of new medicines aimed at improving the health and quality of life of patients in the region. The national regulation that holds down prices & profits and results in market fragmentation is anticipated to be a major factor that differentiates the strengths of the European research-based industry and its American counterparts in the pharma sector.

Key Companies & Market Share Insights

Most of the key companies are concentrated in the developed regions, such as Europe and North America, resulting in a well-established supply chain and production system in these regions. However, manufacturers are shifting their bases to emerging countries, such as Brazil, India, and China, due to low labor costs and high growth opportunities. The generic sector, in particular, is expected to drive the demand for pharma glass packaging in these countries over the forecast period.

Many companies invest in business expansion and product R&D. For instance, SGD S.A has been upgrading its plants in China and Spain with advanced equipment to boost production. In August 2018, the company had invested approximately USD 7.8 million to rebuild the furnace and has boosted production by 11%. Some of the prominent players in the global pharmaceutical glass packaging market include:

  • Corning Incorporated

  • Nipro Corporation

  • SGD S.A.

  • Stölzle-Oberglas GmbH

  • Bormioli Pharma S.r.l

  • West Pharmaceutical Services, Inc.

  • Schott AG

  • Gerresheimer AG

  • Shandong Medicinal Glass Co., Ltd.

  • Beatson Clark

  • Ardagh Group S.A.

  • Arab Pharmaceutical Glass Co.

  • Piramal Enterprises Ltd.

  • Şişecam Group

  • Owens-Illinois, Inc.

Pharmaceutical Glass Packaging Market Report Scope

Report Attribute

Details

Market size value in 2021

USD 17,047.0 million

Revenue forecast in 2028

USD 30,876.1 million

Growth Rate

CAGR of 8.6% from 2021 to 2028 (Revenue-based)

Base year for estimation

2020

Historical data

2017 - 2019

Forecast period

2021 - 2028

Quantitative units

Revenue in USD million/billion, volume in million units, and CAGR from 2021 to 2028

Report coverage

Revenue forecast, volume forecast, company ranking, competitive landscape, growth factors, and trends

Segments covered

Product, drug type, region

Regional scope

North America; Europe; Asia Pacific; Central & South America; Middle East & Africa

Country scope

U.S.; Canada; Mexico; U.K.; Germany; France; Italy; Spain; China; Japan; India; South Korea; Australia; Brazil; Saudi Arabia

Key companies profiled

Corning, Inc.; Nipro Corp.; SGD S.A.; Stölzle-Oberglas GmbH; Bormioli Pharma S.r.l; West Pharmaceutical Services, Inc.; Schott AG; Gerresheimer AG; Shandong Medicinal Glass Co., Ltd.; Beatson Clark; Ardagh Group S.A.; Arab Pharmaceutical Glass Co.; Piramal Enterprises Ltd.; Şişecam Group; Owens-Illinois, Inc.

Customization scope

Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options


Segments Covered in the Report

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2017 to 2028. For the purpose of this study, Grand View Research has segmented the global pharmaceutical glass packaging market report on the basis of product, drug type, and region:

  • Product Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)

    • Vials

      • Small Vials

      • Large Vials

    • Bottles

      • Small Bottles

      • Large Bottles

    • Cartridges & Syringes

    • Ampoules

  • Drug Type Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)

    • Generic

    • Branded

    • Biologic

  • Regional Outlook (Volume, Million Units; Revenue, USD Million, 2017 - 2028)

    • North America

      • U.S.

      • Canada

      • Mexico

    • Europe

      • U.K.

      • Germany

      • France

      • Italy

      • Spain

    • Asia Pacific

      • China

      • Japan

      • India

      • South Korea

      • Australia

    • Central & South America

      • Brazil

    • Middle East & Africa (MEA)

      • Saudi Arabia

Frequently Asked Questions About This Report

Pricing & Purchase Options

Service Guarantee

  • Insured Buying

    This report has a service guarantee. We stand by our report quality.

  • Confidentiality

    We are in compliance with GDPR & CCPR norms. All interactions are confidential.

  • GDPR.EU
  • Custom research service

    Design an exclusive study to serve your research needs.

  • 24/5 Research support

    Get your queries resolved from an industry expert.

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities